Literature DB >> 3355765

Response to flavone acetic acid (NSC 347512) of primary and metastatic human colorectal carcinoma xenografts.

R Giavazzi1, A Garofalo, G Damia, S Garattini, M D'Incalci.   

Abstract

The antitumour activity of flavone acetic acid (FAA) was evaluated against two human colorectal carcinoma (HCC) lines, HCC-P2988 and HCC-M1410, transplanted into nude mice. On repeated i.v. injection of 200 mg kg-1 every 4 days FAA was moderately active against the s.c. growing HCC-P2988. HCC-M1410 transplanted s.c. was almost unresponsive in the same experimental conditions. In contrast, FAA (200 mg kg-1 i.v. every 4 days, repeated three times) significantly reduced liver tumour colonies produced by the HCC-M1410 cells injected intrasplenically into nude mice. These findings suggest that FAA has potential activity against human colorectal carcinoma, particularly against liver metastases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3355765      PMCID: PMC2246519          DOI: 10.1038/bjc.1988.59

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

1.  Different sensitivity to cytostatic drugs of primary tumor and metastasis of the Lewis carcinoma.

Authors:  C Tropé
Journal:  Neoplasma       Date:  1975       Impact factor: 2.575

2.  Concepts for systemic treatment of micrometastases.

Authors:  F M Schabel
Journal:  Cancer       Date:  1975-01       Impact factor: 6.860

3.  Antiproliferative properties of flavone acetic acid (NSC 347512) (LM 975), a new anticancer agent.

Authors:  L S Capolongo; G Balconi; P Ubezio; R Giavazzi; G Taraboletti; A Regonesi; O C Yoder; M D'Incalci
Journal:  Eur J Cancer Clin Oncol       Date:  1987-10

4.  Differential distribution of antitumor agents in primary and secondary tumors.

Authors:  M G Donelli; T Colombo; M Broggini; S Garattini
Journal:  Cancer Treat Rep       Date:  1977-10

5.  Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice.

Authors:  R Giavazzi; D E Campbell; J M Jessup; K Cleary; I J Fidler
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

6.  Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice.

Authors:  J Plowman; V L Narayanan; D Dykes; E Szarvasi; P Briet; O C Yoder; K D Paull
Journal:  Cancer Treat Rep       Date:  1986-05

Review 7.  Some aspects of size-dependent differential drug response in primary and metastatic tumors.

Authors:  I Abe; M Suzuki; K Hori; S Saito; H Sato
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

8.  Phase I and pharmacokinetic study of LM985 (flavone acetic acid ester).

Authors:  D J Kerr; S B Kaye; J Graham; J Cassidy; M Harding; A Setanoians; J C McGrath; W R Vezin; D Cunningham; G Forrest
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

Review 9.  Clinical perspective of human colorectal cancer metastasis.

Authors:  D A August; R T Ottow; P H Sugarbaker
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

10.  The influence of site of metastasis on tumour growth and response to chemotherapy.

Authors:  N H Slack; I D Bross
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

View more
  11 in total

1.  Flavone acetic acid antitumour activity against a mouse pancreatic adenocarcinoma is mediated by natural killer cells.

Authors:  G Damia; G Tagliabue; P Allavena; M D'Incalci
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  Identification and induction of cytochrome P450s involved in the metabolism of flavone-8-acetic acid in mice.

Authors:  Minh Hien Pham; Hervé Rhinn; Nicolas Auzeil; Anne Regazzetti; Djamel Eddine Harami; Daniel Scherman; Guy G Chabot
Journal:  Drug Metab Lett       Date:  2011-04

3.  Flavone acetic acid (LM-975; NSC-347512) activation to cytotoxic species in vivo and in vitro.

Authors:  G G Chabot; M C Bissery; A Gouyette
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Flavone acetic acid distribution in human malignant tumors.

Authors:  G Damia; A Freschi; R Sorio; A Braida; G Caruso; M Quaia; S Monfardini; M D'Incalci
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

5.  Interaction between endotoxin and the antitumour agent 5,6-dimethylxanthenone-4-acetic acid in the induction of tumour necrosis factor and haemorrhagic necrosis of colon 38 tumours.

Authors:  L M Ching; W R Joseph; L Zhuang; B C Baguley
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

6.  Flavone acetic acid--an interesting novel therapeutic agent or just another disappointment?

Authors:  M C Bibby
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

7.  The relationship between tissue levels of flavone acetic acid (NSC 347512) and site dependent anti-tumour activity in murine colon tumours.

Authors:  M C Bibby; R M Phillips; J A Double
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

8.  Differential efficacy of flavone acetic against liver versus lung metastases in a human tumour xenograft.

Authors:  G Pratesi; C Manzotti; M Tortoreto; R A Audisio; F Zunino
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

9.  Anti-tumour activity of flavone acetic acid (NSC 347512) in mice--influence of immune status.

Authors:  M C Bibby; R M Phillips; J A Double; G Pratesi
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

10.  Response of chemically induced primary colon tumours of the mouse to flavone acetic acid (NSC 347 512).

Authors:  G Pratesi; C Manzotti; G Damia; M D'Incalci
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.